Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8807951 | Pathophysiology | 2017 | 30 Pages |
Abstract
Alzheimer's disease (AD) is a developmental neurodegenerative disorder for which there is no effective treatment or cure at present. In this study, the neuroprotective properties of a methanol extract of the leaves of Kigelia africana (KAE) and its flavonoid-rich fraction (FKAE) in aluminum chloride (AlCl3)-induced experimental AD was evaluated. Symptoms mimicking AD were induced in male Sprague Dawley rats by administering 17Â mg/kg AlCl3, orally, for six consecutive weeks. Pretreatment of animals with 50 and 100Â mg/kg KAE or FKAE for two weeks, followed by their co-administration with AlCl3 for a further four weeks ameliorated neurological deficits, cerebral oxidative stress, neurochemical disturbances and histoarchitectural alterations caused by AlCl3 intoxication. The results suggest that KAE and FKAE are promising therapeutic agents for AD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
John Adeolu Falode, Afolabi C. Akinmoladun, M. Tolulope Olaleye, Afolabi A. Akindahunsi,